UBS Group’s Xtrackers US National Critical Technologies ETF CRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-969
Closed -$34.4K 10521
2026
Q1
$34.4K Buy
+969
New +$35.7K ﹤0.01% 7602
2025
Q4
Sell
-1,547
Closed -$56.4K 10599
2025
Q3
$56.4K Buy
+1,547
New +$54.4K ﹤0.01% 7478
2025
Q1
Sell
-100
Closed -$3.12K 10288
2024
Q4
$3.12K Sell
100
-301
-75% -$9.62K ﹤0.01% 8930
2024
Q3
$12.6K Buy
+401
New +$12.2K ﹤0.01% 7627

Other funds holding CRTC

UBS Group's CRTC Position: Q2 2026 in Review

UBS Group sold out of Xtrackers US National Critical Technologies ETF (CRTC) in Q2 2026, closing a stake of 969 shares — an estimated $34.4K sold.

UBS Group first reported a position in CRTC in Q3 2024 and held it in 4 quarters. The position peaked at $56.4K in Q3 2025. 30 funds tracked by Wall St. Rank hold CRTC as of Q2 2026.

  • UBS Group reported no remaining Xtrackers US National Critical Technologies ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 969 Xtrackers US National Critical Technologies ETF shares in Q2 2026, an estimated $34.4K.
  • UBS Group first reported a position in Xtrackers US National Critical Technologies ETF in Q3 2024 and held it in 4 quarters.
  • UBS Group's Xtrackers US National Critical Technologies ETF position peaked at $56.4K in Q3 2025.
  • 30 funds tracked by Wall St. Rank held Xtrackers US National Critical Technologies ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.